OPEN END CALL TURBO ZERTIFIKAT - ROCHE Share Price

Certificat

DE000NG8QX67

Real-time Boerse Frankfurt Warrants 02:46:42 16/07/2024 pm IST
16.57 EUR -1.13% Intraday chart for OPEN END CALL TURBO ZERTIFIKAT - ROCHE
Current month+5.14%
1 month+4.62%
Date Price Change
16/24/16 16.57 -1.13%
15/24/15 16.76 +2.32%
12/24/12 16.38 +2.25%
11/24/11 16.02 +0.38%
10/24/10 15.96 +3.91%

Real-time Boerse Frankfurt Warrants

Last update July 16, 2024 at 02:46 pm IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer ING Bank
WKN NG8QX6
ISINDE000NG8QX67
Date issued 15/05/2024
Strike 122.9 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 12
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 17
Lowest since issue 12.96
Spread 0.08
Spread %0.48%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
258.7 CHF
Average target price
274 CHF
Spread / Average Target
+5.91%
Consensus